Royal College of Nursing ends partnership with Teva UK
Britain’s Royal College of Nursing has ended its commercial partnership with Teva UK, an Israeli drug company. The union also removed the company as sponsor of an upcoming migraine and headache event at its London headquarters, citing concerns about Teva’s links to Israel’s military and its corporate misconduct record.
Britain’s Royal College of Nursing has cut ties with Teva UK, an Israeli drug company, ending the firm’s role as a commercial partner of the nursing union.
The RCN also removed Teva UK as sponsor of a forthcoming event on migraine and headaches. The event is due to take place at the union’s London headquarters.
The union’s decision was attributed to concerns about Teva’s links to Israel’s military and what the source describes as the company’s track record of corporate misconduct.
THE QUESTIONS THIS EVENT LEAVES BEHIND
What process did the Royal College of Nursing use to review Teva UK’s partnership?
What specific links between Teva UK and Israel’s military informed the decision?
How will the event’s sponsorship and funding arrangements change?
What response has Teva UK given to the union’s decision?
Could the decision affect the RCN’s future commercial partnerships?
YOUR QUESTION
Does this story leave you with another question?
Send us the question the report did not answer. It may become the next question IAQ investigates.
GLOBAL CURIOSITY MAP · SEPTEMBER 2026